Allworth Financial’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$148K Sell
1,490
-99
-6% -$8.92K ﹤0.01% 1700
2026
Q1
$138K Buy
1,589
+60
+4% +$5.25K ﹤0.01% 1626
2025
Q4
$130K Buy
1,529
+99
+7% +$7.9K ﹤0.01% 1591
2025
Q3
$104K Sell
1,430
-108
-7% -$7.45K ﹤0.01% 1667
2025
Q2
$101K Buy
1,538
+108
+8% +$7.03K ﹤0.01% 1551
2025
Q1
$94.5K Hold
1,430
﹤0.01% 1258
2024
Q4
$95.4K Sell
1,430
-423
-23% -$29.1K ﹤0.01% 1285
2024
Q3
$131K Buy
1,853
+159
+9% +$11.1K ﹤0.01% 960
2024
Q2
$115K Buy
1,694
+156
+10% +$10.2K ﹤0.01% 1021
2024
Q1
$104K Sell
1,538
-1
-0.1% -$66 ﹤0.01% 1007
2023
Q4
$95K Hold
1,539
﹤0.01% 963
2023
Q3
$90.7K Hold
1,539
﹤0.01% 915
2023
Q2
$91.8K Hold
1,539
﹤0.01% 921
2023
Q1
$89.8K Hold
1,539
﹤0.01% 892
2022
Q4
$95.4K Hold
1,539
﹤0.01% 825
2022
Q3
$87K Buy
1,539
+3
+0.2% +$185 ﹤0.01% 807
2022
Q2
$98K Hold
1,536
﹤0.01% 720
2022
Q1
$99K Sell
1,536
-111
-7% -$7.04K ﹤0.01% 726
2021
Q4
$110K Hold
1,647
﹤0.01% 661
2021
Q3
$101K Buy
1,647
+567
+53% +$36K ﹤0.01% 614
2021
Q2
$67K Hold
1,080
﹤0.01% 552
2021
Q1
$64K Buy
+1,080
New +$65.1K ﹤0.01% 523

Other funds holding IHE

Allworth Financial's IHE Position: Q2 2026 in Review

Allworth Financial reduced its iShares US Pharmaceuticals ETF (IHE) stake by 6.2% in Q2 2026, selling an estimated $8.92K and leaving 1,490 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #1700.

Allworth Financial first reported a position in IHE in Q1 2021 and has held it in 22 quarters since. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Allworth Financial held 1,490 shares of iShares US Pharmaceuticals ETF worth $148K as of Q2 2026.
  • Allworth Financial sold 99 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $8.92K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1700 holding.
  • Allworth Financial first reported a position in iShares US Pharmaceuticals ETF in Q1 2021 and has held it in 22 quarters since.
  • 209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.